We are thrilled to announce that Cyberating, the emerging leader in cyber risk management, has successfully raised €2,000,000 in its latest funding round. This significant investment marks a pivotal moment for the company as it charges ahead with its visionary ambition to become Europe’s most relevant cyber rating agency. Leveraging over 20 years of rich industry experience, Cyberating has consistently demonstrated its commitment to innovation and excellence, making it a trusted partner for organizations grappling with the increasingly complex landscape of cyber threats. The funds will be strategically allocated to further develop the company’s cutting-edge platform, which not only identifies cyber risks but also automates their control, effectively streamlining a process that has traditionally been labor-intensive and prone to error. This enhanced platform aims to provide businesses, large and small, with real-time insights and robust assessments that empower them to make informed decisions about their cybersecurity investments. In today’s digital era, where adaptive and proactive risk management is crucial, Cyberating’s initiative bridges a critical gap in the market by offering a reliable, data-driven approach to cyber risk rating. The funding will also support the expansion of the company’s research and development team, aiming to refine and innovate its technology further, ensuring that its solutions remain at the forefront of cybersecurity advancements. With this injection of capital, Cyberating is set to drive significant progress towards its mission, reinforcing its position as a trailblazer in the European cyber risk arena and ultimately contributing to a safer digital future for businesses across the continent.
Cyberating Secures $2M in Pre-Seed Funding to Launch Europe’s Premier Cyber Rating Platform
Get the full Cyberating company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Mediads
Mediads, the Social Ads Amplification Platform, allows you to combine your content with the reputation of the biggest media brands! All from your advertising account (your audiences, pixel and campaign history). Aimed at SMEs, DNVBs, e-merchants, pure players, start-ups, scale-ups and large groups, Mediads' innovation maximises the return on investment (ROI, ROAS) of performance advertising campaigns by winning the trust of their targets and audiences. The result: a +50% to +250% improvement in its clients' advertising performance. Our exclusive proprietary technology simplifies and guarantees the validation of advertisers and their campaigns (creative and messages) with our media partners, guaranteeing the effectiveness and security of exchanges and the launch of online campaigns. Translated with www.DeepL.com/Translator (free version)
$3.5M Seed
today
Handle.com
Fortune 500 material suppliers and contractors trust Handle software on a daily basis to provide their credit and finance departments with an end-to-end solution. Purpose-built for material suppliers and equipment dealers to manage the entire process of online payments and lien management.
$27.0M Series b
today
Texas Automated Robotics Systems, LLC
Tars Robotics, based in Houston Texas, strives to equip manufacturers with the highest quality robotic automation equipment at the most economical value in the industry. Our goal is to enable as many American manufacturers with the ability to compete in the global injection molding industry. We continue to support the initiative to re-shore products from all industries back to the United States. We offer a wide and unique line of robotic arms for machines ranging from 30 tons to 4,000 tons while providing the best solutions no matter how intelligible or complex. With our customer’s need in mind, our product lines include a diverse series of robots designed for sprue and parts removal, insert molding, de-gating, in-mold labeling, and parts stacking.
$513.0M Seed
today
Viseur AI - Digital Pathology Platform
Viseur AI is a digital pathology and medical imaging platform built to become the operating system of AI-enabled diagnostics. We unify Pathology Information Management (PIMS), Digital Pathology / WSI viewing (IMS), AI model deployment and governance, and enterprise-grade integrations into a single, vendor-agnostic platform designed for real clinical workflows. Healthcare systems and diagnostic labs struggle with fragmented pathology workflows, scanner-locked software, and AI solutions that rarely reach routine clinical use. Viseur AI addresses this by delivering an end-to-end digital pathology platform from specimen to report, combining enterprise-grade WSI viewing, AI model deployment and management, on-prem or hybrid architectures aligned with data privacy and regulatory requirements, and deep LIS, HIS, and PACS integrations that enable standardised and scalable operations across multiple sites. Certified under ISO 13485, ISO 27001, and ISO/IEC 15504-SPICE, Viseur AI creates a foundation for clear and compatible AI in healthcare.
$350.0K Seed
today
Imperagen
Imperagen is advancing enzyme engineering through an integrated, AI-driven platform that enables faster and more precise development of high-performance enzymes. By combining advanced computational modeling with automated lab testing, we help companies improve production processes while reducing cost, time, and environmental impact. Founded by researchers from the Manchester Institute of Biotechnology, Imperagen brings together expertise in physics-based simulation, machine learning, and high-throughput experimentation. Our closed-loop platform continuously learns from real-world data, allowing us to design, test, and refine enzymes with greater accuracy and efficiency than traditional approaches . We take a problem-specific approach, tailoring each solution to the unique requirements of a given enzyme, reaction, and application. We work with organizations across pharma, life sciences, chemicals, food, and consumer goods to solve complex enzyme engineering challenges. Our approach helps reduce development risk, shorten timelines, and support the shift toward more sustainable, enzyme-based manufacturing. Get in touch to learn more about our innovative platform and discover how we can quickly transform your enzyme needs into market-ready solutions.
$6.4M Seed
today
Other recent Pre-seed rounds
Companies that recently closed a Pre-seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Synakis Canada | Pre-seed | $2.6M | today |
| 2 |  shatterdome energy India | Pre-seed | $3.5M | 1d ago |
| 3 |  Meta Fashion India | Pre-seed | $400.0K | 1d ago |
| 4 |  AVIAN Switzerland | Pre-seed | $2.6M | 2d ago |
| 5 |  EvoTouch | Pre-seed | $332.8K | 2d ago |